Welcome to Urgent Family Care

November 3, 2014
Company News

Welcome to the new website of Urgent Family Care. This is our first blog post announcing the launch of our newly designed website, we hope you like it.

CDC Recommends the First Updated COVID-19 Booster Targeting Omicron BA.4 and BA.5

CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendations for use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older.

COVID-19 | Medical Editorial | Convalescent plasma is ineffective for covid-19

Convalescent plasma generated great enthusiasm in the earliest days of the coronavirus disease 2019 (covid-19) pandemic because of a plausible mechanism of action, its 100 year history of use in the treatment of other infectious diseases, and rapid availability from voluntary donors.

COVID-19 | Medical Research Study | Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Research Abstract Objective: To investigate the effectiveness of using convalescent plasma to treat moderate coronavirus disease 2019 (covid-19) in adults in India.

Welcome to Urgent Family Care

Related Post

CDC Recommends the First Updated COVID-19 Booster Targeting Omicron BA.4 and BA.5

COVID-19 | Medical Editorial | Convalescent plasma is ineffective for covid-19

COVID-19 | Medical Research Study | Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)